Pfiz­er peni­cillin re­call im­per­ils syphilis treat­ment sup­ply, par­tic­u­lar­ly for preg­nant women

A re­cent drug re­call of Pfiz­er’s peni­cillin prod­uct has put the im­me­di­ate sup­ply of a key syphilis treat­ment at risk, ac­cord­ing to the com­pa­ny and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.